Biomarkers of inflammation in heart failure.

Abstract:

:Heart failure (HF) is characterized by the elaboration of a portfolio of pro-inflammatory cytokines and inflammatory mediators that are considered to contribute to disease progression by virtue of the deleterious effects that these molecules exert on the heart and circulation. Recent studies have suggested that these inflammatory mediators may serve as relevant markers of disease severity and HF prognosis. Moreover, there is evidence that changes in the levels of inflammatory biomarkers may prove useful in following the change in patient clinical status following institution of appropriate HF therapy. This review will focus on the emerging role of inflammatory biomarkers, including pro-inflammatory cytokines, C-reactive protein, and erythrocyte sedimentation rate in patients with HF.

journal_name

Heart Fail Rev

journal_title

Heart failure reviews

authors

Bozkurt B,Mann DL,Deswal A

doi

10.1007/s10741-009-9140-3

subject

Has Abstract

pub_date

2010-07-01 00:00:00

pages

331-41

issue

4

eissn

1382-4147

issn

1573-7322

journal_volume

15

pub_type

杂志文章,评审
  • Pharmacological treatment of chronic heart failure.

    abstract::Heart failure (HF) is associated with a high morbidity and mortality in the Western World. Our knowledge of the epidemiology, pathophysiology, and therapy has improved dramatically during the last 20 years. Pharmacological treatment, as it stands today, is a combination of preventive and symptomatic strategies. The ma...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-006-9482-z

    authors: Adorisio R,De Luca L,Rossi J,Gheorghiade M

    更新日期:2006-06-01 00:00:00

  • Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome.

    abstract::The prevalence of heart failure (HF) is increasing. A distinction is made between diastolic HF (preserved left ventricular ejection fraction (LVEF)) and systolic HF (reduced LVEF). Advanced glycation end-products (AGEs) are crystallized proteins that accumulate during ageing, but are particularly increased in patients...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-010-9225-z

    authors: Willemsen S,Hartog JW,Heiner-Fokkema MR,van Veldhuisen DJ,Voors AA

    更新日期:2012-03-01 00:00:00

  • Treatment of congestion in heart failure with diuretics and extracorporeal therapies: effects on symptoms, renal function, and prognosis.

    abstract::In the United States and Europe, approximately 90% of heart failure hospitalizations are due to symptoms and signs of sodium and fluid excess. Congestion is associated with heart failure progression. Venous congestion, rather than a reduced cardiac output, may be the primary hemodynamic factor driving worsening renal ...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-011-9248-0

    authors: Costanzo MR,Jessup M

    更新日期:2012-03-01 00:00:00

  • The therapeutic effect of natriuretic peptides in heart failure; differential regulation of endothelial and inducible nitric oxide synthases.

    abstract::The abnormal regulation of nitric oxide synthase activity represents an underlying feature of heart failure. Increased peripheral vascular resistance, and decreased renal function may be in part related to impaired endothelium-dependent nitric oxide (NO) synthesis. Paradoxically, the chronic production of NO by induci...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1023/a:1022147005110

    authors: Calderone A

    更新日期:2003-01-01 00:00:00

  • Erythropoietin: a future therapy for failing hearts?

    abstract::Recently, it has been suggested that erythropoietin may be useful in the treatment of cardiovascular disease, particularly heart failure. This may be by improving microvascular blood supply and ventricular function through prevention of apoptosis and angiogenesis. Promising results were seen in animals but the few, li...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-011-9288-5

    authors: Tilling L,Clapp B

    更新日期:2012-05-01 00:00:00

  • Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure.

    abstract::Sympathetic-parasympathetic interaction plays a major role in the evolution and outcome of many cardiovascular disorders. Nonetheless, a thorough understanding of this relationship and of its potential implications for prognosis and management still escapes many cardiologists. This article reviews the background of sy...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-010-9179-1

    authors: Schwartz PJ,De Ferrari GM

    更新日期:2011-03-01 00:00:00

  • Cell death, tissue hypoxia and the progression of heart failure.

    abstract::An important feature of heart failure is the progressive deterioration of left ventricular function that occurs in the absence of clinically apparent intercurrent adverse events. The mechanism or mechanisms responsible for this hemodynamic deterioration are not known. We and others have advanced the hypothesis that th...

    journal_title:Heart failure reviews

    pub_type: 杂志文章

    doi:10.1023/A:1009880720032

    authors: Sabbah HN,Sharov VG,Goldstein S

    更新日期:2000-06-01 00:00:00

  • Diagnostic value of echocardiographic markers for diastolic dysfunction and heart failure with preserved ejection fraction.

    abstract::This study aimed to evaluate the diagnostic performance of echocardiographic markers of heart failure with preserved ejection fraction (HFpEF) and left ventricular diastolic dysfunction (LVDD) in comparison with the gold standard of cardiac catheterization. Diagnosing HFpEF is challenging, as symptoms are non-specific...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-020-09985-1

    authors: Dal Canto E,Remmelzwaal S,van Ballegooijen AJ,Handoko ML,Heymans S,van Empel V,Paulus WJ,Nijpels G,Elders P,Beulens JW

    更新日期:2020-06-02 00:00:00

  • Patient selection for mechanical circulatory support.

    abstract::Heart failure continues to be associated with high morbidity and mortality. Over the past decade, left ventricular assist devices have been shown to improve the survival and quality of life. However, it is quite clear that very sick patients do not do as well, and it is therefore imperative to select patients at the p...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-012-9316-0

    authors: Gilotra NA,Russell SD

    更新日期:2013-01-01 00:00:00

  • Cardiac metabolism in hypertrophy and heart failure: implications for therapy.

    abstract::The heart consumes huge amounts of energy to fulfil its function as a relentless pump. A highly sophisticated system of energy generation based on flexibility of substrate use and efficient energy production, effective energy sensing and energy transfer ensures function of the healthy heart across a range of physiolog...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-012-9359-2

    authors: Siddiqi N,Singh S,Beadle R,Dawson D,Frenneaux M

    更新日期:2013-09-01 00:00:00

  • Aerobic exercise effect on prognostic markers for systolic heart failure patients: a systematic review and meta-analysis.

    abstract::From previous systematic reviews and meta-analyses, there is consensus about the positive effect of exercise training on exercise capacity for systolic heart failure (HF); however, the effect on actual prognostic markers such as NTproBNP and minute ventilation/carbon dioxide production (VE/VCO2) slope has not been eva...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,meta分析,评审

    doi:10.1007/s10741-013-9407-6

    authors: Cipriano G Jr,Cipriano VT,da Silva VZ,Cipriano GF,Chiappa GR,de Lima AC,Cahalin LP,Arena R

    更新日期:2014-09-01 00:00:00

  • Mechanistic implications of altered protein expression in rheumatic heart disease.

    abstract::Rheumatic heart disease (RHD) is a major cause of cardiovascular morbidity and mortality in low- and middle-income countries, where living conditions promote spread of group A β-haemolytic streptococcus. Autoimmune reactions due to molecular mimicry of bacterial epitopes by host proteins cause acute rheumatic fever (A...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-020-09993-1

    authors: Lumngwena EN,Skatulla S,Blackburn JM,Ntusi NAB

    更新日期:2020-07-11 00:00:00

  • Hyperuricemia: a novel old disorder-relationship and potential mechanisms in heart failure.

    abstract::Uric acid, the metabolic mediator of gout and urate renal stones, is associated with increased cardiovascular risk burden. Hyperuricemia is an old emerging metabolic disorder, and interaction among uric acid and cardiovascular diseases has been clearly described. Several illness including hypertension, myocardial infa...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-019-09869-z

    authors: Borghi C,Palazzuoli A,Landolfo M,Cosentino E

    更新日期:2020-01-01 00:00:00

  • Aminopeptidase N in arterial hypertension.

    abstract::Aminopeptidase N (APN) or CD13 is a conserved type II integral membrane zinc-dependent metalloprotease in the M1 family of ectoenzymes. APN is abundant in the kidneys and central nervous system. Identified substrates include Angiotensin III (Ang III); neuropeptides, including enkephalins and endorphins; and homones, i...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-007-9061-y

    authors: Danziger RS

    更新日期:2008-09-01 00:00:00

  • B-type natriuretic peptide: physiologic role and assay characteristics.

    abstract::The discovery of cardiac natriuretic peptides two decades ago has lead to considerable research to investigate their biochemical and physiological properties. Clearly the heart is not just a pump but is also an endocrine organ that together with the kidneys control volume overload. The natriuretic peptides are a group...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1023/a:1026182912461

    authors: Azzazy HM,Christenson RH

    更新日期:2003-10-01 00:00:00

  • Principals and clinical applications of magnetic resonance cardiac spectroscopy in heart failure.

    abstract::Cardiac magnetic resonance spectroscopy (MRS) is a noninvasive method to assess by-products of myocardial metabolism. Recent developments in shorter scan protocols and more powerful field strengths have created interest in utilizing this technology in studying and characterizing the metabolic derangements in heart fai...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-017-9611-x

    authors: Qureshi WT,Nasir UB

    更新日期:2017-07-01 00:00:00

  • Infarct size reduction and attenuation of global left ventricular remodeling with the CorCap cardiac support device following acute myocardial infarction in sheep.

    abstract:BACKGROUND:Whether mechanical restraint of the left ventricle (LV) can influence remodeling following myocardial infarction (MI) remains poorly understood. The following discussion details three studies examining the effects of surgically placing a cardiac support device (CSD) over the entire epicardial surface, on inf...

    journal_title:Heart failure reviews

    pub_type: 杂志文章

    doi:10.1007/s10741-005-4640-2

    authors: Blom AS,Pilla JJ,Gorman RC 3rd,Gorman JH,Mukherjee R,Spinale FG,Acker MA

    更新日期:2005-06-01 00:00:00

  • Renin-angiotensin-system inhibition in the context of corona virus disease-19: experimental evidence, observational studies, and clinical implications.

    abstract::Coronavirus disease 2019 (COVID-19) is due to severe acute respiratory syndrome coronavirus (SARS-CoV)-2 which binds and enters the host cells through the angiotensin-converting enzyme (ACE)2. While the potential for benefit with the use of renin-angiotensin-aldosterone system inhibitors (RAASi) and the risks from sto...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-020-10022-4

    authors: Triposkiadis F,Starling RC,Xanthopoulos A,Butler J,Boudoulas H

    更新日期:2020-09-01 00:00:00

  • Understanding non-response to cardiac resynchronisation therapy: common problems and potential solutions.

    abstract::Heart failure is a complex clinical syndrome associated with a significant morbidity and mortality burden. Reductions in left ventricular (LV) function trigger adaptive mechanisms, leading to structural changes within the LV and the potential development of dyssynchronous ventricular activation. This is the substrate ...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-018-9734-8

    authors: Sieniewicz BJ,Gould J,Porter B,Sidhu BS,Teall T,Webb J,Carr-White G,Rinaldi CA

    更新日期:2019-01-01 00:00:00

  • Beta-adrenergic stimulation and myocardial function in the failing heart.

    abstract::The sympathetic nervous system provides the most powerful stimulation of cardiac function, brought about via norepinephrine and epinephrine and their postsynaptic beta-adrenergic receptors. More than 30 years after the first use of practolol in patients with heart failure beta blockers are now the mainstay of the phar...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-008-9132-8

    authors: El-Armouche A,Eschenhagen T

    更新日期:2009-12-01 00:00:00

  • Definition, epidemiology and registries of pulmonary hypertension.

    abstract::Pulmonary arterial hypertension (PAH) is a subcategory of pulmonary hypertension (PH) that comprises a group of disorders with similar pulmonary vascular pathology. Though PH is common, the estimated incidence of IPAH is 1-3 cases per million, making it a rare disease. The hemodynamic definition of PAH is a mean pulmo...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-015-9510-y

    authors: Awdish R,Cajigas H

    更新日期:2016-05-01 00:00:00

  • Practical considerations for BNP use.

    abstract::The evolving paradigm of heart failure has now been expanded to include the favorable neurohormonal, structural and hemodynamic profile of B-type natriuretic peptide [BNP]. As a marker of left ventricular dysfunction, BNP is a practical tool that facilitates diagnosis, contributes to prognostic evaluations and tracks ...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1023/a:1026107701983

    authors: Yancy CW

    更新日期:2003-10-01 00:00:00

  • Classical inotropes and new cardiac enhancers.

    abstract::Acute heat failure syndromes are a heterogenous group of conditions. Chronic heart failure exacerbations represent the vast majority of cases. Pathophysiologic mechanisms, such as hypotension with peripheral tissue hypoperfusion, renal function impairment and myocardial ischemia and injury, adversely affect patients' ...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-007-9014-5

    authors: Parissis JT,Farmakis D,Nieminen M

    更新日期:2007-06-01 00:00:00

  • Unraveling new mechanisms of exercise intolerance in chronic heart failure: role of exercise training.

    abstract::Despite remarkable progress in the therapeutic approach of patients with chronic heart failure (CHF), exercise intolerance remains one of the hallmarks of the disease. During the past two decades, evidence has accumulated to underscore the key role of both endothelial dysfunction and skeletal muscle wasting in the pro...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-012-9324-0

    authors: Conraads VM,Van Craenenbroeck EM,De Maeyer C,Van Berendoncks AM,Beckers PJ,Vrints CJ

    更新日期:2013-01-01 00:00:00

  • Effect of exercise on epicardial adipose tissue in adults: a systematic review and meta-analyses.

    abstract::According to previous epidemiological studies, we can reduce the thickness of epicardial fat and improve cardiovascular risk factors through exercise, and the changes may depend on the form of exercise. We systemically reviewed published studies that evaluated exercise intervention on epicardial adipose tissue (EAT) l...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-020-09965-5

    authors: Colonetti T,Grande AJ,Amaral MC,Colonetti L,Uggioni ML,da Rosa MI,Hernandez AV,Tse G,Liu T,Nerlekar N,Biondi-Zoccai G,Neto MG,Durães AR,Pontes-Neto O,Resende ES,Roever L

    更新日期:2020-05-16 00:00:00

  • Anti-fibrotic effects of curcumin and some of its analogues in the heart.

    abstract::Cardiac fibrosis stems from the changes in the expression of fibrotic genes in cardiac fibroblasts (CFs) in response to the tissue damage induced by various cardiovascular diseases (CVDs) leading to their transformation into active myofibroblasts, which produce high amounts of extracellular matrix (ECM) proteins leadi...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-019-09854-6

    authors: Gorabi AM,Hajighasemi S,Kiaie N,Rosano GMC,Sathyapalan T,Al-Rasadi K,Sahebkar A

    更新日期:2020-09-01 00:00:00

  • Sarcomeric proteins in hypertrophied and failing myocardium: an overview.

    abstract::This collection of papers covers developments in a rapidly growing area, sarcomeric proteins in hypertrophied and failing myocardium. Advances in our understanding of the biochemistry and biophysics of crossbridge cycling, contributions of thick versus thin filament and the emerging role of titin, the importance and m...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-005-5247-3

    authors: LeWinter MM,VanBuren P

    更新日期:2005-09-01 00:00:00

  • Cardiorespiratory fitness in patients with type 2 diabetes: A missing piece of the puzzle.

    abstract::Functional capacity represents an important predictor for cardiovascular and all-cause mortality in patients with diabetes mellitus (DM). Impaired cardiopulmonary fitness is frequently seen in DM patients, and it might partly explain morbidity and mortality in these patients. There are several potential reasons that c...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-020-10015-3

    authors: Tadic M,Grassi G,Cuspidi C

    更新日期:2020-08-15 00:00:00

  • Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging.

    abstract::Although several risk factors including hypertension, cardiac hypertrophy, coronary artery disease, and diabetes are known to result in heart failure, elderly subjects are more susceptible to myocardial infarction and more likely to develop heart failure. This article is intended to discuss that cardiac dysfunction in...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-011-9278-7

    authors: Dhalla NS,Rangi S,Babick AP,Zieroth S,Elimban V

    更新日期:2012-09-01 00:00:00

  • Current and future role of cardiovascular magnetic resonance in cardiac resynchronization therapy.

    abstract::Cardiac resynchronization therapy (CRT) has revolutionized the treatment of selected patients with systolic heart failure. It is well recognized, however, that the symptomatic response to and the outcome of CRT is highly variable. The degree of pre-implant mechanical dyssynchrony and the extent as well as the localiza...

    journal_title:Heart failure reviews

    pub_type: 杂志文章,评审

    doi:10.1007/s10741-010-9213-3

    authors: Leyva F,Foley PW

    更新日期:2011-05-01 00:00:00